Congrats to client and healthcare technology revenue cycle management (RCM) innovator Boost Healthcare on its acquisition by Aspirion, the industry’s RCM leader for denials, payment variance, and complex claims. Boost’s revenue recovery and advisory services help healthcare providers focus on patient experience and quality of care, while reducing revenue loss and claims denials. In announcing the acquisition, Aspirion called out Boost’s expertise in zero-balance review, payment variance, denials management, and No Surprise Act compliance.

Procopio Mergers & Acquisitions Co-Leader and Partner Jason Femrite led the deal negotiations on behalf of Boost, with the assistance of Partner Jessica Lazur and Associate Gabi Turner, as well as tax, intellectual property, privacy, and employment attorneys.

Boost Founder and Managing Partner Liana Hamilton said of the transaction: “Joining the Aspirion family marks an exciting new chapter for Boost Healthcare. Our shared commitment to innovation and client success makes this partnership particularly powerful. Aspirion’s technological infrastructure and automation capabilities will amplify our ability to deliver best-in-class results, ensuring healthcare providers maintain the financial stability needed to serve their patients’ needs effectively.” Hamilton and her team will stay on with Aspirion after the transition.

Learn more in Aspirion’s press release.